Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

NCT00192374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1920

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: CAIV-T, Liquid

Sponsor

MedImmune LLC

Collaborators

[object Object]